🤖 AI in Drug Discovery - Nova $TAO Subnet 68
This article summarizes a podcast episode discussing the application of AI in drug discovery, specifically within the context of Nova $TAO Subnet 68 and its role in molecular search. The episode also touches upon patenting and community value considerations.
Key Points:
• AI accelerates drug discovery by streamlining molecular search.
• AI aids in identifying promising drug candidates.
• Patenting and community value are discussed in the context of AI-driven discoveries.
🔗 Resources:
• MetaNova Labs ↗ - AI drug discovery company
• Hash Rate Podcast ↗ - Episode 99 featuring MetaNova Labs
• micaelabazo ↗ - MetaNova Labs guest
• pennapdr ↗ - MetaNova Labs guest
Image
💡 Health2Tech Event - Digital Health Startup Extinction
This article announces a Health2Tech event featuring a presentation on the challenges facing digital health startups.
Key Points:
• Presentation on the "Mass Extinction of Digital Health Startups."
• Event takes place March 19th in New York.
• Partnership with AIHealthUncut, jcness, and StartupGrindNYC.
🔗 Resources:
• AIHealthUncut ↗ - Speaker at the event
• Health2Tech ↗ - Event page
• jcness ↗ - Partner organization
• StartupGrindNYC ↗ - Partner organization
Image
✨ Health Data Rewards - $RJV Token
This article describes a tokenized reward system for user engagement with health data.
Key Points:
• Users earn rewards for contributing health data.
• Connects with wearable devices.
• Rewards users for their participation in their longevity journey.
🔗 Resources:
• Rejuve AI ↗ - Developer of the $RJV token
Image
🤖 Access to GLP-1 Medications - Cost Barriers
This article highlights a Scientific American article discussing cost barriers to accessing GLP-1 medications.
Key Points:
• High cost of GLP-1 medications is a significant barrier for patients.
• Patients often stop taking GLP-1s due to cost, impacting their health.
• The article explores the reasons behind patients discontinuing treatment.
🔗 Resources:
• Truveta ↗ - Source of the information
• Scientific American ↗ - Publication featuring the article
Image
Image
🤖 Top GU Cancer Trials - February 2025
This article presents a curated list of the top 10 clinical trials in genitourinary (GU) cancer for February 2025.
Key Points:
• Top 10 GU cancer trials curated by Larvol CLIN and Bluestar BioAdvisors.
• List includes trials like TALAPRO2, CheckMate274, and NIAGARA.
• Provides insights into current oncology research.
🔗 Resources:
• Larvol ↗ - Curator of the clinical trial list
Image
Image
Image
Image
💡 Cancer Risk Factors - Understanding Your Risk
This article discusses the importance of understanding cancer risk factors to make informed health decisions.
Key Points:
• Cancer risk is influenced by genetics, lifestyle, and environment.
• Understanding risk allows for proactive health management.
• Risk factors include family history, lifestyle choices, and environmental exposures.
🔗 Resources:
• MassiveBio ↗ - Source of the infographic
Image
Image
Image
Image
💡 Injury Recovery - The PEACE Principles
This article outlines the PEACE principles for injury recovery.
Key Points:
• PEACE stands for Protection, Elevation, Avoid, Compression, Education.
• Provides a framework for effective injury management.
• Emphasizes self-care and informed decision-making in recovery.
🔗 Resources:
• EQL AI ↗ - Source of the PEACE principles
🤖 AI in Pathology - Owkin Dx Blog Series
This article announces a whitepaper on AI pathology models. The whitepaper will discuss transitioning from traditional slide analysis to AI-powered medical devices.
Key Points:
• Explores the transition from traditional microscopy to AI in pathology.
• Highlights the crucial role of data in AI pathology model creation.
• Provides a comprehensive analysis of AI pathology model development.
🔗 Resources:
• Owkin Science ↗ - Publisher of the whitepaper
Image
🤖 AI and Health Equity - Qure.ai's TB Initiative
This article discusses how AI can contribute to health equity, using Qure.ai's tuberculosis (TB) initiative as an example.
Key Points:
• AI technology assists in the fight against tuberculosis.
• The initiative supports TB survivors globally.
• The company emphasizes its commitment to improving health equity.
🔗 Resources:
• Qure.ai ↗ - Developer of the AI technology
Image
🤖 AGI vs. LLM - Model Context Protocol (MCP)
This article discusses the differences between Artificial General Intelligence (AGI) and Large Language Models (LLMs), focusing on the Model Context Protocol (MCP).
Key Points:
• AGI is self-evolving and self-emerging software.
• LLMs, AI agents, and MCP are not considered AGI.
• A sufficiently intelligent LLM might render MCP unnecessary.
🔗 Resources:
• 0xTsuan ↗ - Source of the discussion
Image
⭐️ Support
If you liked reading this report, please star ⭐️ this repository and follow me on Github ↗, 𝕏 (previously known as Twitter) ↗ to help others discover these resources and regular updates.
